LD50 LC50 Mixture:ORAL LD50(RAT): 7,930 MG/KG (GLYCINE)
Routes of Entry: Inhalation:YES Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:A SYSTEMIC REACTION SUCH AS ANY
GENERALIZED RASH, TACHYCARDIA, DYSPNEA, HYPOTENSION/ANAPHYLAXIS MAY
BE SEEN FOLLOWING EXPOSURE TO EQUINE ANTIBODY & ANTIGENIC PROTEINS.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:A SYSTEMIC REACTION SUCH AS ANY GENERALIZED
RASH, TACHYCARDIA, DYSPNEA, HYPOTENSION/ANAPHYLAXIS MAY BE SEEN
FOLLOWING EXPOSURE TO EQUINE ANTIBODY & ANTIGENIC PROTEINS.
Medical Cond Aggravated by Exposure:PRIOR EXPOSURE & SENSITIVITY TO
EQUINE GAMMA GLOBULIN PROTEINS.
======================= First Aid Measures =======================
Eyes: FLUSH W/WATER FOR 15 MINS. SKIN: WASH W/SOAP & WATER.
INHALATION: REMOVE FROM EXPOSURE. OBTAIN MEDICAL ATTENTION IN ALL
CASES.
===================== Fire Fighting Measures =====================
Flash Point:NONFLAMMABLE
Extinguishing Media:WATER, CO2/DRY CHEMICAL
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS &
FULLY BODY PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:NONE
Spill Release Procedures:PROVIDE VENTILATION & PERSONAL PROTECTION TO
PREVENT OVEREXPOSURE. KEEP PRODUCT OUT OF DRAINS; PREVENT ENTRY TO
SURFACE WATER, GROUNDWATER & SOIL. SMALL: ABSORB W/PAPER
TOWEL/APPROPRIATE MEDIA. LARGE: VACUUM/SCOOP & PLACE IN A SUITABLE
CONTAINER.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORE IN A COOL, DRY PLACE & PROTECT
FROM LIGHT. KEEP OUT OF REACH OF CHILDREN.
Other Precautions:AVOID CONTACT W/SKIN, EYES & CLOTHING.
Respiratory Protection:NOT REQUIRED.
Ventilation:LOCAL EXHAUST.
Protective Gloves:RUBBER
Eye Protection:SAFETY GLASSES W/SIDE SHIELDS.
Other Protective Equipment:PROTECTIVE COVERING FOR EXPOSED AREAS OF
SKIN.
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
ATGAM STERILE SOLUTION IS A HUMAN DRUG USED IN IMMUNOSUPPRESSIVE
THERAPY.
Waste Disposal Methods:DISPOSE OF BY INCINERATION IN ACCORDANCE
W/LOCAL, STATE & FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.